ANIP
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- ANI Pharmaceuticals reports positive Phase 4 results from the open-label, single-arm SYNCHRONICITY trial, presented as a late-breaking oral presentation at the 2026 American Academy of Ophthalmology Annual MeetingOct 12, 2026
- ANI Pharmaceuticals receives FDA approval for everolimus tablets for oral suspensionSep 23, 2026
- ANI Pharmaceuticals reported positive six-month topline data from the Phase 4 SYNCHRONICITY trialJul 13, 2026
- ANI Pharmaceuticals received FDA approval and launched pimozide tablets with 180-day CGT exclusivityApr 20, 2026
- ANI Pharmaceuticals received FDA approval and launched isosorbide mononitrate tabletsApr 8, 2026